Poor-quality red blood cell labelling with technetium-99m: case report and review of the literature
暂无分享,去创建一个
[1] S. Srivastava,et al. Radionuclide-labeled red blood cells: current status and future prospects. , 1984, Seminars in nuclear medicine.
[2] P Richards,et al. Cardiac chamber imaging: a comparison of red blood cells labeled with Tc-99m in vitro and in vivo. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] H. Dworkin,et al. Acid-citrate-dextrose compared with heparin in the preparation of in vivo/in vitro technetium-99m red blood cells. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] C. Rabito,et al. Radiolabeling of erythrocytes with technetium-99m: role of band-3 protein in the transport of pertechnetate across the cell membrane. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] M. Blaufox,et al. Left ventricular ejection fraction and its response to therapy in essential hypertension. , 1981, Nephron.
[6] R. Hicks,et al. Efficiency of labelling of red blood cells with technetium-99m after dipyridamole infusion for thallium-201 stress testing , 1992, European Journal of Nuclear Medicine.
[7] W. W. Miller,et al. Pitfall to Modified In Vivo Method of Technetium–99m Red Blood Cell Labeling: lodinated Contrast Media , 1983, Clinical nuclear medicine.
[8] J P Wexler,et al. Pharmacologic alterations in Tc-99m binding by red blood cells: concise communication. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] B. Rhodes,et al. Drug-induced changes in the biologic distribution of radiopharmaceuticals. , 1982, Seminars in nuclear medicine.